Articles

Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes

Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia;
Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia;
Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia;
University of Melbourne, Peter MacCallum Cancer Centre, Melbourne, Australia;
Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia;
Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia;
Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia;
Royal Children's Hospital, Melbourne,
Royal Children's Hospital, Melbourne,
Royal Children's Hospital, Melbourne,
Transfusion Research Unit, Monash University, Melbourne
Clinical Haematology, Peter MacCallum Cancer Centre/Royal Melbourne Hospital, Melbourne
Clinical Haematology, Peter MacCallum Cancer Centre/Royal Melbourne Hospital, Melbourne
Children Health Queensland and University of Queensland, South Brisbane, QLD
Children Health Queensland and University of Queensland, South Brisbane, QLD,
Department of Hematology, Austin Health, Melbourne,
Melbourne Genomics Health Alliance, Parkville VIC, Australia
Melbourne Genomics Health Alliance, Parkville VIC
Melbourne Genomics Health Alliance, Parkville VIC, Australia
Clinical Haematology, Peter MacCallum Cancer Centre/Royal Melbourne Hospital, Melbourne, Australia;
Vol. 106 No. 1 (2021): January, 2021 https://doi.org/10.3324/haematol.2019.237693